Evidence map›Paper›PMID 32610442›Full record

ArticlePharmaceutics2020

Formulation Development of Mucoadhesive Microparticle-Laden Gels for Oral Mucositis: An In Vitro and In Vivo Study.

Hiroomi Sakurai, Yuri Ikeuchi-Takahashi, Ayaka Kobayashi, Nobuyoshi Yoshimura, Chizuko Ishihara, Tohru Aomori, Hiraku Onishi

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hiroomi SakuraiDepartment of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
Yuri Ikeuchi-TakahashiDepartment of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo 142-8501, Japan.
Ayaka KobayashiOsaka R&D Center, Mitsubishi Chemical Corporation, 2-13-1 Muroyama, Ibaraki, Osaka 567-0052, Japan.
Nobuyoshi YoshimuraOsaka R&D Center, Mitsubishi Chemical Corporation, 2-13-1 Muroyama, Ibaraki, Osaka 567-0052, Japan.
Chizuko IshiharaOsaka R&D Center, Mitsubishi Chemical Corporation, 2-13-1 Muroyama, Ibaraki, Osaka 567-0052, Japan.
Tohru AomoriDepartment of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
Hiraku OnishiDepartment of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo 142-8501, Japan.
Mitsubishi Chemical (Japan) · JPHoshi University · JPEbara (Japan) · JPKeio University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to relieve pain due to oral mucositis, we attempted to develop mucoadhesive microparticles containing indomethacin (IM) and gel preparations with IM microparticles that can be applied to the oral cavity. The mucoadhesive microparticles were prepared with a simple composition consisting of IM and polyvinyl alcohol (PVA). Two kinds of PVA with different block properties were used, and microparticles were prepared by heating-filtration and mixing-drying. From the X-ray powder diffraction patterns, differential scanning calorimetry thermograms, and morphological features of the IM microparticles, IM should exist as polymorphic forms in the microparticles. Rapid drug release properties were observed in the IM microparticles. Increased drug retention was observed in IM microparticles containing PVA, and the IM-NK(50) gel, using a common block character PVA and heating-filtration, showed good long-term drug retention properties. In vivo experiments showing significantly higher drug concentrations in the oral mucosa were observed with IM microparticles prepared by heating-filtration, and the IM-NK(50) gel maintained significantly higher drug concentrations in the oral mucosa. From these results, the IM-NK(50) gel may be useful as a preparation for relieving oral mucositis pain.

Indexed as

crystal polymorphindomethacinmucoadhesive microparticlesoral mucositispolyvinyl alcohol

Identifiers

PMID32610442
PMCPMC7408005
OpenAlexW3037935734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.